Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
Launched by MICHIGAN STATE UNIVERSITY · Mar 30, 2020
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Scaling Up," is looking at a program designed to help pregnant women who may be at risk for alcohol use. The program, called MommyCheckup, is a technology-based tool that helps these women screen for alcohol use and provides brief interventions to encourage them to reduce their drinking. The researchers want to see if this program is effective and whether additional support, like follow-up sessions or personalized text messages, can make it work even better.
To be eligible for this study, women need to be between 18 and 35 years old, currently pregnant, and have identified alcohol use risks. They should be no more than 20 weeks along in their pregnancy and planning to give birth in Connecticut, Massachusetts, or Michigan. Participants will use their mobile devices to receive reminders and complete online activities related to the study. If you or someone you know fits these criteria, this study could provide valuable support during pregnancy while also contributing to important research on alcohol use and its effects on developing babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-35 years
- • Pregnant
- • Self-report of alcohol risk (those who score positive on the T-ACE screen (Sokol, Martier, \& Ager, 1989), and also report either drinking weekly or more in the past month, or having 4 or more drinks at a time at least monthly in the 12 months before becoming pregnant
- • 20 weeks or less gestation
- • Planning to give birth in either Connecticut, Massachusetts, or Michigan
- • Owning a mobile device that they are willing to use to receive study-related text reminders and to complete online study activities including assessments/boosters
- • Completion of baseline assessment (enrollment criterion)
- Exclusion Criteria:
- • Not planning to carry the baby to term
- • Unable to communicate in English
About Michigan State University
Michigan State University (MSU) is a leading public research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, MSU integrates cutting-edge research methodologies and expert faculty across various fields to address pressing health challenges. The university's commitment to ethical research practices and participant safety ensures that all clinical trials are conducted with the highest standards of integrity and compliance. By fostering a dynamic environment for scientific inquiry, MSU aims to translate research findings into practical solutions that enhance patient care and contribute to the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Flint, Michigan, United States
Patients applied
Trial Officials
Steven J Ondersma, PhD
Principal Investigator
Michigan State University
Kimberly A Yonkers, MD
Principal Investigator
University of Massachusetts, Worcester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials